PTGER4 and cancer: A recent study has exploited CS‐hyaluronate‐SPION nanoparticles for the delivery of siRNA and EP4 antagonist in cancer therapy; these nanoparticles effectively suppress HIF‐1α/EP4 axis in impairing growth and invasion of tumor cells.63